SMA Highlights: Updates from Biogen

October 26, 2021


pdf File Biogen Q3 2021 SMA Community Statement (2).pdf (613KB) [download]

Biogen is excited to share several highlights from the last few months. We Biogen announced the presentation of new data from the SPINRAZA ® (nusinersen) clinical development program and their plans to initiate a new clinical research study called ASCEND.

View more information.